Financial insights of SXTPW

MyFinsight

For the year ending 2025-12-31, SXTPW made $1,005,471 in revenue. -$7,365,158 in net income. Net profit margin of -732.51%.

Income Statement	2025-12-31
Product revenues net of discounts and rebates	1,005,471
Cost of revenues	781,695
Gross profit	223,776
Research revenues	403,624
Net revenue	627,400
Research and development	2,106,156
General and administrative expenses	6,279,823
Total operating expenses	8,385,979
Loss from operations	-7,758,579
Interest expense	7,805
Change in fair value of derivative liabilities	266,089
Other income, net	131,970
Total interest and other income (expense), net	390,254
Loss from operations before provision for income taxes	-7,368,325
Provision for income taxes (note 9)	0
Net loss	-7,368,325
Net loss noncontrolling interest	-3,167
Net loss attributed to 60 degrees pharmaceuticals, inc	-7,365,158

Basic EPS	-11.73
Diluted EPS	-11.73
Basic Average Shares	670,211
Diluted Average Shares	670,211